Emergent BioSolutions CEO presents at J.P. Morgan Healthcare Conference; no new data

Emergent BioSolutions Inc.

CEO Joe Papa presented at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
Investor slides furnished as Exhibit 99.1 contain no specific financial results or guidance updates.
No material business or operational changes disclosed in the filing or exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.